Aprogen pharmaceuticals,Inc. (003060.KS)

KRW 704.0

(-4.22%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 589.39 Billion 676.1 Billion 614.62 Billion 615.3 Billion 365.28 Billion 217.06 Billion
Total Current Assets 84.85 Billion 240.6 Billion 353.47 Billion 336.52 Billion 213.54 Billion 87.28 Billion
Cash And Short Term Investments 10.05 Billion 99.07 Billion 124.93 Billion 205.07 Billion 92.5 Billion 62.46 Billion
Cash and Cash Equivalents 10.05 Billion 23.6 Billion 35.07 Billion 64.79 Billion 30.29 Billion 21.63 Billion
Short Term Investments - 75.46 Billion 89.86 Billion 140.27 Billion 62.21 Billion 40.83 Billion
Net Receivables 26.19 Billion 89.45 Billion 222.3 Billion 125.44 Billion 118.02 Billion 16.4 Billion
Inventory 48.12 Billion 52.31 Billion 10.41 Billion 10.03 Billion 8.75 Billion 8.39 Billion
Other Current Assets 476.86 Million -237.75 Million -4.18 Billion -4.03 Billion -5.74 Billion 23.09 Million
Total Non-Current Assets 504.53 Billion 435.49 Billion 261.14 Billion 278.78 Billion 151.73 Billion 129.77 Billion
Net PPE 318.21 Billion 323.77 Billion 18.85 Billion 19.8 Billion 45.9 Billion 17.32 Billion
Good Will And Intangible Assets 6.24 Billion 6.45 Billion 2.79 Billion 3.63 Billion 3.5 Billion 3.29 Billion
Good Will - - - - - -
Intangible Assets 6.24 Billion 6.45 Billion 2.79 Billion 3.63 Billion 3.5 Billion 3.29 Billion
Long-Term Investments 180.05 Billion -17.67 Billion -5.62 Billion -36.17 Billion 29.75 Billion 66.68 Billion
Tax Assets 4.00 662.84 Million 755.7 Million 658.88 Million 793.38 Million 749.41 Million
Other Non Current Assets 27.98 Million 122.27 Billion 244.36 Billion 290.87 Billion 71.77 Billion 41.71 Billion
Other Assets - - - 10.00 - -
Total Liabilities 220.7 Billion 173.72 Billion 17.44 Billion 16.95 Billion 17.64 Billion 66.55 Billion
Total Current Liabilities 157.93 Billion 161.1 Billion 9.44 Billion 8.67 Billion 10.81 Billion 62.04 Billion
Account Payables 1.33 Billion 3.8 Billion 652.59 Million 808.22 Million 535.87 Million 707.67 Million
Tax Payables 409.78 Million 4.17 Million 273.93 Million 461.17 Million - 79.15 Million
Short Term Debt 130.72 Billion 134.6 Billion 2.36 Billion 2.8 Billion 3.63 Billion 38 Billion
Deferred Revenue 194.33 Million 543.16 Million 6.43 Billion 5.05 Billion 6.64 Billion 23.32 Billion
Other Current Liabilities 25.69 Billion 22.14 Billion 160.00 320.00 720.00 280.00
Total Non Current Liabilities 62.76 Billion 12.62 Billion 7.99 Billion 8.27 Billion 6.83 Billion 4.5 Billion
Long-Term Debt 32 Billion 129.05 Million 120 Million 163.91 Million 228.01 Million -
Deferred Revenue Non Current 18.27 Billion - - 7.18 Billion - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 9.55 Billion 9.38 Billion 6.77 Billion -10.00 6.6 Billion 4.5 Billion
Other Liabilities 1.00 10.00 - - - 10.00
Total Equity 368.69 Billion 502.37 Billion 597.18 Billion 598.35 Billion 347.63 Billion 150.51 Billion
Stock Holders Equity 368.69 Billion 421.71 Billion 507.93 Billion 505.39 Billion 246.34 Billion 150.51 Billion
Common Stock 332.87 Billion 292.87 Billion 199.28 Billion 199.28 Billion 120.82 Billion 53.94 Billion
Retained Earnings -328.84 Billion -12.88 Billion -21.11 Billion -30.11 Billion -41.77 Billion -33.28 Billion
Accumulated other comprehensive income 11.09 Billion 5.85 Billion 2.5 Billion 8.96 Billion 2.08 Billion 10.15 Billion
Common Stock Equity 368.69 Billion 421.71 Billion 507.93 Billion 505.39 Billion 246.34 Billion 150.51 Billion
Capital Lease Obligation 18.27 Billion 474.56 Million 319.49 Million 349.69 Million 416.66 Million -
Total Investments 180.05 Billion 57.79 Billion 84.23 Billion 104.09 Billion 91.96 Billion 107.52 Billion
Total Debt 180.99 Billion 134.73 Billion 2.48 Billion 2.97 Billion 3.86 Billion 38 Billion
Net Debt 170.94 Billion 111.12 Billion -32.59 Billion -61.82 Billion -26.43 Billion 16.37 Billion

Balance Sheet Charts